Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

NCT06876636 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DRUG: Zoledronic Acid Combined with Neoadjuvant Chemotherapy (EC-T)

Sponsor

Xijing Hospital